Highlights Duearity AB

Equities

DEAR

SE0015949482

Market Closed - Nasdaq Stockholm Other stock markets 10:16:03 2024-06-05 EDT			5-day change	1st Jan Change
0.1156 ^SEK	-3.51%		-64.76%	-94.79%

05-31	Duearity AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-11	Duearity Unit Signs US Distribution Deal With Westone Laboratories	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Duearity AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-31	CI
Duearity Unit Signs US Distribution Deal With Westone Laboratories	03-11	MT
Duearity Americas Inc Enters into an Agreement with Westone Laboratories	03-10	CI
Duearity AB Reports Earnings Results for the Fourth Quarter and Eight Months Ended December 31, 2023	02-22	CI
Duearity AB Reports Earnings Results for the Third Quarter and Five Months Ended September 30, 2023	11-30	CI
Duearity AB Signs Distributor Agreement - Covering Belgium, the Netherlands and Luxembourg	23-10-02	CI
Sweden's Duearity Lands Deals for Tinnitus Device in US	23-08-25	MT
Duearity Americas Inc Signs Agreements with the First Clinics in the United States	23-08-25	CI
Duearity AB Reports Earnings Results for the Second Quarter Ended June 30, 2023	23-08-24	CI
Duearity, Prime Health Distribution Enter UK Distribution Deal	23-07-27	MT
Duearity AB Enters into an Agreement with a Distributor in Great Britain	23-07-27	CI
Duearity Announces Positive Results from Duearity's User Study on People with Tinnitus	23-06-05	CI
Duearity AB Signs Distributor Agreement	23-05-23	CI
Duearity AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Duearity AB Receives Market Approval in the UK	23-04-26	CI
Duearity AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Duearity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23	CI
Duearity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
Duearity to Submit an Application for Approval of A Tinnitus Product in the United States	22-10-31	CI
Duearity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Duearity AB

Equities

DEAR

SE0015949482

Highlights

Filters